Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M006606200 on September 28, 2000

J. Biol. Chem., Vol. 275, Issue 51, 40187-40194, December 22, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/51/40187    most recent
M006606200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fagan, K. A.
Right arrow Articles by Cooper, D. M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fagan, K. A.
Right arrow Articles by Cooper, D. M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of a Ca2+-sensitive Adenylyl Cyclase in an Excitable Cell

ROLE OF VOLTAGE-GATED VERSUS CAPACITATIVE Ca2+ ENTRY*

Kent A. FaganDagger , Robert A. GrafDagger , Shawna Tolman§, Jerome Schaack§, and Dermot M. F. CooperDagger

From the Departments of Dagger  Pharmacology and § Microbiology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Received for publication, July 24, 2000, and in revised form, September 20, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In nonexcitable cells, we had previously established that Ca2+-sensitive adenylyl cyclases, whether expressed endogenously or heterologously, were regulated exclusively by capacitative Ca2+ entry (Fagan, K. A., Mahey, R. and Cooper, D. M. F. (1996) J. Biol. Chem. 271, 12438-12444; Fagan, K. A., Mons, N., and Cooper, D. M. F. (1998) J. Biol. Chem. 273, 9297-9305). Relatively little is known about how these enzymes are regulated by Ca2+ in excitable cells, where they predominate. Furthermore, no effort has been made to determine whether the prominent voltage-gated Ca2+ entry, which typifies excitable cells, overwhelms the effect of any capacitative Ca2+ entry that may occur. In the present study, we placed the Ca2+-stimulable, adenylyl cyclase type VIII in an adenovirus vector to optimize its expression in the pituitary-derived GH4C1 cell line. In these cells, a modest degree of capacitative Ca2+ entry could be discerned in the face of a dramatic voltage-gated Ca2+ entry. Nevertheless, both modes of Ca2+ entry were equally efficacious at stimulating adenylyl cyclase. A striking release of Ca2+ from intracellular stores, triggered either by ionophore or thyrotrophin-releasing hormone, was incapable of stimulating the adenylyl cyclase. It thus appears as though the intimate colocalization of adenylyl cyclase with capacitative Ca2+ entry channels is an intrinsic property of these molecules, regardless of whether they are expressed in excitable or nonexcitable cells.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ca2+-sensitive adenylyl cyclases provide a means of coordinating the activities of the two major signaling systems of cAMP and Ca2+ (1). The fact that these cyclases are regulated by Ca2+ entering the cells ensures an acute response of the cAMP-generating system to the elevation of [Ca2+]i.1 In nonexcitable cells, we have previously shown a strict dependence for capacitative Ca2+ entry (CCE) as the mode of [Ca2+]i elevation that would regulate Ca2+-sensitive adenylyl cyclases, whether they were expressed endogenously or heterologously (2, 3). In particular, Ca2+ released from internal stores by any mechanism was unable to regulate adenylyl cyclase activity (4), whereas Ca2+ entering via CCE modulated cAMP synthesis positively or negatively, depending on the adenylyl cyclase species expressed (2, 3). These findings have now been extended to other nonexcitable cell systems (5-7). Although the endogenous Ca2+-stimulable adenylyl cyclase of cerebellar granule cells (8) and of hippocampal slices (9) is stimulated by Ca2+ influx through voltage-gated calcium channels (VGCCs), it is not known whether adenylyl cyclases in excitable cells are as discriminating as those expressed in nonexcitable cells for the nature of the Ca2+ rise to which they respond. In the present study, the Ca2+-stimulable ACVIII was placed in an adenovirus vector to provide efficient expression in the excitable, anterior pituitary-derived tumor line, GH4C1. GH4C1 cells are spontaneously electrically active and express VGCCs that give rise to prominent intracellular rises in [Ca2+]i upon membrane depolarization (10). They also express TRH receptors coupled to phospholipase C that elevate [Ca2+]i both by inositol 1,4,5-trisphosphate-linked mechanisms and by modifying the activity of VGCCs (11). It seemed possible that GH4C1 cells, like most neuronal cells, might not display prominent CCE; however, if CCE was detectable, the opportunity would be provided to determine whether any selectivity was displayed in the regulation of the adenylyl cyclase for either type of [Ca2+]i rise in the same cell type.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Thapsigargin and forskolin were from Calbiochem. [2-3H]Adenine and [alpha -32P]ATP were obtained from Amersham Pharmacia Biotech. Fura-2/AM and pluronic acid were from Molecular Probes, Inc. (Eugene, OR). Other reagents were from Sigma.

Cells and Viruses-- Viruses were constructed and propagated using HEK 293 cells, a human embryonic kidney cell line transformed by and expressing high levels of Ad5 E1A and E1B proteins (12). The virus used for recombination was Ad5dl327Bstbeta -gal, which encodes LacZ in place of the E1A and E1B genes and permits color screening for recombinant viruses (13). Ad5dl327Bstbeta -gal was purified after infection of HEK 293 cells at maximal cytopathic effect, releasing the virus from the concentrated cell pellet by three cycles of rapid freezing and thawing; the cell debris was pelleted and re-extracted twice by resuspension in a small volume of phosphate-buffered saline followed by rapid freezing and thawing and pelleting of the cell debris. The supernatants were combined and banded for 50 min at 36,000 rpm using a CsCl step gradient consisting of 1 ml of 1.4 g/ml CsCl in phosphate-buffered saline and 1.5 ml of 1.25 g/ml CsCl in phosphate-buffered saline in a SW40 rotor. The virion band was collected by side puncture, diluted in 1.35 g/ml CsCl in phosphate-buffered saline, and rebanded for 3 h at 65,000 rpm in a VTi65 rotor. The virion band was again collected by side puncture. To prepare Ad5dl327Bstbeta -gal-terminal protein (TP) complex, the sample was diluted in 4 M guanidine-HCl and 2.8 M CsCl (14) and banded overnight at 65,000 rpm using a VTi65 rotor. The gradient was fractionated by dripping and fractions containing DNA were identified by agarose gel electrophoresis of aliquots. DNA-containing fractions were combined and dialyzed versus 6 changes of 2 liters each of 10 mM Tris-HCl, pH 8.0, 10 mM NaCl, and 0.2 mM EDTA at 4 °C. The presence of TP on the DNA greatly increases the infectivity after transfection (15), presumably due to both increased nuclear uptake facilitated by the nuclear localization signal in TP and protection of the DNA from degradation. Ad5dl327Bstbeta -gal-TP was digested with BstBI. For analysis of the completion of digestion, an aliquot was digested with proteinase K before agarose gel electrophoresis. BstBI-digested Ad5dl327Bstbeta -gal-TP was aliquoted and stored at -20 °C.

Plasmid Construction-- A cDNA encoding ACVIII was cloned into pACCMV under the control of the cytomegalovirus major immediate early promoter (CMV promoter; Ref. 16) to yield pACCMV-ACVIII, which places expression under the control of the CMV promoter, and into the plasmid pXC15E1A#12 to yield pXC15E1A-ACVIII, which places expression under the control of the adenovirus type 5 E1A promoter. pXC15E1A-ACVIII was further modified by insertion of a BstBI adaptor in the SalI site between the 3' end of the ACVIII coding sequence and the sequences encoding the intron and poly(A) sites (which are contributed by the 3' end of the E1B gene) to generate pXC15E1A-ACVIIIBst.

Transfections-- HEK 293 cells at approximately 70% confluence were transfected using a modified calcium phosphate procedure (17) using 6 µg of plasmid DNA and approximately 0.2 µg of Ad5dl327Bstbeta -gal-TP complex. Cells were incubated with the transfection solution overnight before being fed with fresh medium.

Construction of Adenovirus Transducing Vector Encoding ACVIII-- Because cAMP is a prominent regulator of cell growth and numerous cellular processes, it would be expected that adenylyl cyclase expression would be tightly regulated and constrained to low levels (18). Thus, whereas attempts were made to construct transducing viruses placing ACVIII expression under the control of both the strong CMV promoter and weaker E1A promoters, it was expected that the use of the E1A promoter would yield a virus that directed expression at a level closer to the normal level. The use of the E1A promoter was also expected to make construction and growth of the virus easier because high-level expression of the cyclase might be expected to alter expression of a variety of genes and interfere specifically with regulation of adenovirus gene expression (e.g., Refs. 19-22). In addition to being a generally weaker promoter than the CMV promoter, the activity of the E1A promoter is inhibited by the high level of E1A protein expressed in HEK 293 cells (23 and data not shown). Attempts to introduce pXC15E1A-ACVIII into BstBI-digested Ad5dl327Bstbeta -gal-TP by standard overlap recombination (13, 24) were unsuccessful. As an alternative, ligation of the modified plasmid, pXC15E1A-ACVIIIBst, with the large, right arm of the adenovirus chromosome-TP complex was used. 6 µg of pXC15E1A#12-ACVIIIBst was digested with BstBI to generate a ligation site for the viral arm and with XmnI, which cleaves in the beta -lactamase coding sequence within the plasmid vector backbone to leave a blunt end, to inhibit recircularization of the plasmid as well as ligation to form concatamers. The restriction enzyme-digested plasmid was ligated with Ad5dl327Bstbeta -gal-TP complex that had been digested with BstBI. The ligation mix was used to transfect HEK 293 cells to generate the virus. It was expected that expression of ACVIII during the transfection would be significantly reduced because of the reduction in the number of ACVIII templates that contained exon and poly(A) sequences. Furthermore, direct ligation with the large arm of Ad5dl327Bstbeta -gal-TP complex was expected to efficiently introduce the E1A-ACVIII cassette into the virus. Ligation to the large arm of adenovirus restores the intron and a poly(A) site provided by the 3' end of the E1B gene, thus ACVIII expression should be directed by the recombinant virus. Plaques were purified from the transfection stock after serial dilution in HEK 293 cells and overlaying with Noble agar-containing medium and serum. Plates were stained with neutral red and 5-bromo-4-chloro-3-indolyl-beta -D-pyranogalactoside 7 days after infection, and clear plaques were picked on day 8. Plaques were grown in HEK 293 cells and tested for the presence of the ACVIII gene by polymerase chain reaction. A positive clone was grown in large stock, purified by banding consecutively on CsCl step and isopycnic gradients as indicated above, and dialyzed versus three changes of 1 liter each of 135 mM NaCl, 10 mM Tris-HCl, pH. 8.0, 1 mM MgCl2, and 50% (v/v) glycerol at 4 °C. The virus particle concentration was determined by reading absorbance at 260 nm, with 1 A260 unit considered equivalent to 1012 particles. The particle:plaque-forming unit ratio was approximately 100:1 for all preparations.

Cell Culture and Infection-- Rat anterior pituitary GH4C1 cells were maintained in 13 ml of Ham's F-10 medium (Life Technologies, Inc.) with 15% (v/v) horse serum and 2.5% fetal bovine serum (Gemini) in 75-cm2 flasks at 37 °C in a humidified atmosphere of 95% air and 5% CO2. 4 × 106 cells were plated on 100-mm culture dishes for infection with the ACVIII construct. 48 h after infection, cells were detached with phosphate-buffered saline containing 0.03% EDTA and used immediately for measurement of cAMP accumulation or [Ca2+]i. The expression of ACVIII was optimized by varying the multiplicity of infection (m.o.i.). GH4C1 cells were infected with m.o.i.s ranging from 0 to 200 and assayed for their ability to be stimulated by Ca2+. After activation of VGCCs, a m.o.i. of 100 and 200 resulted in a robust Ca2+ stimulation of the cyclase of approximately 4- and 5-fold respectively. A m.o.i. of 100 was selected for further experiments to conserve virus stocks.

Measurement of cAMP Accumulation-- cAMP accumulation in intact cells was measured according to the method of Evans et al. (25) as described previously (26), with some modifications. GH4C1 cells on 100-mm culture dishes were incubated in Ham's F-10 medium (90 min at 37 °C) containing [2-3H]adenine (20.0 µCi/dish) to label the ATP pool. The cells were washed once and detached using phosphate-buffered saline containing EDTA (0.03%). The cells were then resuspended in a nominally Ca2+-free Krebs buffer containing 120 mM NaCl, 4.75 mM KCl, 1.44 mM MgSO4, 11 mM glucose, 25 mM HEPES, and 0.1% bovine serum albumin (fraction V) adjusted to pH 7.4 with 2 M Tris base. The resuspended cells were aliquoted (approximately 3 × 105 cells/tube) and used for cAMP determination in triplicate assays. Experiments were carried out at 30 °C in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 100 µM), which was preincubated with the cells for 10 min before a 1-min assay. Unless indicated otherwise, forskolin (10 µM) was included in each assay to increase the cAMP signal. Assays were terminated by the addition of 10% (w/v, final concentration) trichloroacetic acid. The [3H]ATP and [3H]cAMP content of the supernatants was quantified according to the standard Dowex/alumina methodology (27) as described previously (26). Accumulation of cAMP is expressed as the percentage of conversion of [3H]ATP into [3H]cAMP; means ± S.D. of triplicate determinations are indicated.

[Ca2+]i Measurements-- GH4C1 cells (10 × 106/ml) were loaded with Fura-2/AM (2 µM) plus 0.02% pluronic acid in Ham's F-10 media (serum-free media containing 20 mM HEPES and 0.1% bovine serum albumin, pH 7.4) for 45 min at room temperature. The cells were then washed twice with the same media and resuspended at a concentration of 10 × 106 cells/ml. Aliquots (400 µl; 4 × 106 cells) were pelleted, resuspended in nominally Ca2+-free Krebs buffer, and used for [Ca2+]i measurements in a Perkin-Elmer LS50B spectrofluorometer. No differences were seen in [Ca2+]i-traces from infected and uninfected cells. Cell pretreatment with EGTA (0.1 mM) is referred to as the Ca2+-free condition. The 340/380 nm emission ratios were converted to [Ca2+] using the standard formula (28).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The functional expression of ACVIII was determined by biochemical assay. Because adenylyl cyclase type II, a Ca2+-insensitive isoform, is the predominant mRNA in GH4C1 cells (29), the expression of ACVIII activity could be demonstrated conclusively by an increase in cAMP accumulation in response to an elevation in [Ca2+]i. The most robust means of elevating [Ca2+]i in GH4C1 cells is via VGCCs (30). Consequently, VGCCs were activated by membrane depolarization by increasing [K+]o in the presence or absence of extracellular Ca2+ ([Ca2+]o). When assayed with forskolin, control cells showed no response to VGCC-mediated Ca2+ entry, whereas ACVIII-infected cells exhibited a robust stimulation in cAMP accumulation upon Ca2+ entry, yielding an approximately 3.5-fold stimulation compared with the Ca2+-free condition (Fig. 1A). Vasoactive intestinal peptide stimulation of the cyclase via alpha s activation could also be augmented approximately 2.5-fold by VGCC-mediated Ca2+ entry (Fig. 1B). Therefore, the use of an adenovirus construct to express ACVIII provided a simple and efficient means of heterologously expressing this protein in this excitable cell type.



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   Functional expression of ACVIII in GH4C1 cells. GH4C1 cells were infected with the ACVIII/adenovirus construct (at a m.o.i. of 100) 48 h before assay. cAMP accumulation was measured in populations of GH4C1 cells as described under "Experimental Procedures." A, uninfected (open bars) and ACVIII-infected GH4C1 cells (right-hatched bars) were pretreated with IBMX (100 µM) and maintained in Ca2+-free Krebs buffer. cAMP accumulation was measured over a 1-min period starting with the addition of forskolin (10 µM), KCl (20 mM), and the presence or absence of [Ca2+]o (2 mM), as indicated. B, cAMP accumulation was measured in GH4C1 cells infected with the ACVIII/adenovirus as described above, in the presence of vasoactive intestinal peptide (VIP; 200 nM), KCl (20 mM), and the presence or absence of [Ca2+]o (2 mM), as indicated. Basal cAMP accumulation values were 0.3 ± 0.02 and 0.43 ± 0.01 for uninfected and infected cells, respectively. Data are representative of three similar experiments.

Little is known about the regulation of adenylyl cyclases by VGCC-mediated Ca2+ entry in excitable cells. In nonexcitable cells, we have previously established that Ca2+ stimulation of heterologously expressed ACVIII occurs exclusively via CCE. Therefore, we wanted to characterize more fully the ability of VGCCs to regulate ACVIII expressed heterologously in an excitable cell. The activity of VGCCs relies on the membrane potential, which is dictated, in part, by the K+ concentration in the medium bathing the cells. The amount of Ca2+ entry after membrane depolarization with varying [K+]o was assessed (Fig. 2A). Populations of Fura-2-loaded GH4C1 cells were maintained in Ca2+-free Krebs buffer (which contains 4.75 mM KCl). At 300 s, the [K+]o was increased by the addition of KCl (0-20 mM) and CaCl2 (2 mM), which resulted in a rapid, robust [Ca2+]i rise. The magnitude of the peak [Ca2+]i rise ranged from approximately 230 nM to approximately 1050 nM, depending on the [K+]o. The apparently equivalent [Ca2+]i rise elicited by 10 and 20 mM KCl indicates maximal stimulation of the VGCCs by modest membrane depolarization (indeed, addition of 40 mM KCl resulted in a [Ca2+]i rise identical to that elicited by 20 mM KCl; data not shown).



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of increasing [K+]o on VGCC-mediated Ca2+ entry in GH4C1 cells. A, [Ca2+]i was determined in aliquots of 4 × 106 Fura-2-loaded GH4C1 cells as described under "Experimental Procedures." Cells were maintained in nominally Ca2+-free Krebs buffer containing IBMX (100 µM) before the addition of [Ca2+]o (2 mM), along with varying [KCl]o (a, 20 mM; b, 10 mM; c, 5 mM; d, 0 mM), at 300 s. B, cAMP accumulation was measured in ACVIII-infected GH4C1 cells under the same conditions as described above. Cells were assayed in the presence of forskolin (10 µM), ± [Ca2+]o (2 mM), and varying [KCl]o (5 mM, open bars; 10 mM, right-hatched bars; 20 mM, cross-hatched bars), as indicated. Data are representative of three similar experiments.

The ability of the progressive [Ca2+]i rises triggered by incremental [K+]o increases to regulate the exogenously expressed ACVIII was next examined. GH4C1 cells infected with the ACVIII virus were incubated in Ca2+-free Krebs buffer. cAMP accumulation was measured over a 1-min period starting with the addition of forskolin and varying [KCl]o and [Ca2+]o as indicated (Fig. 2B). In the absence of [Ca2+]o, there was no effect of membrane depolarization on cAMP accumulation. Inclusion of [Ca2+]o (2 mM) increased cAMP production at all [K+]o values, with an approximately 2-fold stimulation in the 5 mM [K+]o condition and an approximately 2.8-fold stimulation for the 10 and 20 mM [K+]o conditions. Thus, the observed "plateau" in the ability of high [K+]o to stimulate further Ca2+ entry was reflected in the regulation of ACVIII. Note that the cAMP accumulation is measured over the first minute after the addition of [Ca2+]o, where the [Ca2+]i rises triggered by 10 and 20 mM [K+]o are very similar (cf. Fig. 2A).

The above-mentioned findings showed that a Ca2+-sensitive adenylyl cyclase could be regulated by Ca2+ entry through VGCCs in excitable cells. Furthermore, the magnitude of the stimulation mirrored the extent of Ca2+ entry. We have seen similar results with CCE in nonexcitable cells. In excitable cells, the role of CCE has been explored only sparingly in the face of the much more pronounced [Ca2+]i rise generated by VGCCs. However, we wondered whether CCE was present in excitable cells, if it could also regulate ACVIII, and how this might compare with the regulation by VGCC-mediated Ca2+ entry. CCE is activated by depletion of intracellular Ca2+ stores using the sarcoplasmic/endoplasmic Ca2+-ATPase inhibitor thapsigargin (TG) (31). Treatment of the cells with TG resulted in a modest [Ca2+]i rise (approximately 130 nM) that returned toward baseline because the cells were in Ca2+-free media (Fig. 3A). Addition of [Ca2+]o, either 0.5 or 2 mM, resulted in a rapid [Ca2+]i rise that reached a peak of approximately 230 or 380 nM, respectively, within the time course of the cAMP measurements. Although the [Ca2+]i rise due to CCE was rather robust, it was considerably smaller than the [Ca2+]i rise generated by VGCC-mediated Ca2+ entry (Fig. 3B). Depolarization of the cells with KCl (10 mM) in the presence of either 0.5 or 2 mM [Ca2+]o resulted in peak [Ca2+]i rises of approximately 400 and 550 nM, respectively. Therefore, triggering of CCE by intracellular Ca2+ store depletion resulted in a modest [Ca2+]i rise compared with that arising from VGCC-mediated Ca2+ entry. Next, the ability of CCE and VGCC-mediated Ca2+ entry to stimulate ACVIII was compared. Cells maintained in Ca2+-free Krebs buffer were treated with TG 4 min before the addition of varying [Ca2+]o (Fig. 3C). The stimulation of ACVIII (approximately 3.5-fold) by CCE was apparent at low [Ca2+]o (0.5 mM). Addition of higher [Ca2+]o (2 mM) resulted in further stimulation of ACVIII (approximately 5.2-fold). Comparing the ability of CCE and VGCC-mediated Ca2+ entry to regulate ACVIII, it was apparent that at higher [Ca2+]o, they were very similar, with a slight difference observed at lower [Ca2+]o. The ability of CCE and VGCC-mediated Ca2+ entry to stimulate ACVIII similarly is somewhat surprising in the light of the more robust Ca2+ entry arising from VGCCs (cf. Fig. 3, A and B).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Comparison of CCE and VGCC-mediated Ca2+ entry and their effect on ACVIII-infected GH4C1 cells. A-C, [Ca2+]i and cAMP accumulation was determined in GH4C1 cells as described under "Experimental Procedures." A, cells were maintained in nominally Ca2+-free Krebs buffer containing IBMX (100 µM) before the addition of TG (100 nM; 60 s) followed by the addition of [Ca2+]o (a, 2 mM; b, 0.5 mM) at 300 s. B, cells were incubated in nominally Ca2+-free Krebs buffer containing IBMX (100 µM) before the addition of KCl (10 mM) and [Ca2+]o (a, 2 mM; b, 0.5 mM) at 300 s. C, cAMP accumulation was measured in ACVIII-infected GH4C1 cells under the same conditions as described above. Cells were assayed in the presence of forskolin (10 µM) and [Ca2+]o (0.5 or 2 mM, as indicated). CCE was stimulated with the prior addition of TG (100 nM; open bars), whereas VGCC-mediated Ca2+ entry was triggered with the concomitant addition of KCl (10 mM; hatched bars). Data are representative of two similar experiments.

The clear demonstration of CCE in GH4C1 cells can be difficult because individual GH4C1 cells demonstrate spontaneous Ca2+ oscillations due to intermittent activation of VGCCs, even in "resting" conditions (10). Therefore, in a population of GH4C1 cells, considerable VGCC activity may underlie the magnitude of the Ca2+ entry ascribed to CCE. The extent of VGCC-mediated Ca2+ entry in resting conditions was explored by comparing Ca2+ entry in untreated and TG-treated cells. Untreated cells reveal Ca2+ entry due to spontaneously active VGCCs along with CCE from passive store depletion due to the cells being in Ca2+-free buffer. The L-type VGCC blocker, nimodipine, can then be used to verify the contribution of the predominant L-type VGCC occurring in GH4C1 cells. Populations of Fura-2 loaded GH4C1 cells were either untreated or treated with TG 4 min before the addition of [Ca2+]o (2 mM). Prior treatment of the cells with TG may have augmented the [Ca2+]i rise, giving a peak [Ca2+]i rise of approximately 250 nM (Fig. 4A, trace a), compared with a peak [Ca2+]i rise of approximately 220 nM (Fig. 4A, trace b) in the untreated cells (to illustrate the two traces more clearly, a running average (5-s intervals) of each trace has been overlaid on the actual trace). The magnitude of the [Ca2+]i rise generated by CCE was clearly discerned in the presence of the VGCC blocker nimodipine. Addition of nimodipine (1 µM) along with [Ca2+]o resulted in a greatly reduced [Ca2+]i rise in the untreated cells (approximately 125 nM as compared with 220 nM without nimodipine (Fig. 4A, cf. b versus d)). The effect of nimodipine on TG-treated cells was much less drastic, decreasing the peak [Ca2+]i rise from 250 nM without nimodipine to 180 nM in the presence of the VGCC blocker (Fig. 4A, cf. a versus c). The ability of nimodipine to greatly attenuate the [Ca2+]i rise generated by Ca2+ addition alone illustrated the prominent, spontaneous VGCC-mediated Ca2+ entry occurring in these cells. Accordingly, stimulation of ACVIII by the above-mentioned conditions also revealed the presence of spontaneous VGCC activity. Addition of [Ca2+]o to GH4C1 cells maintained in Ca2+-free Krebs buffer resulted in an approximately 1.5-fold stimulation of ACVIII as compared with the control, Ca2+-free condition (Fig. 4A, inset, open bar versus right-hatched bar). Pretreatment of the cells with TG increased the amount of ACVIII stimulation, resulting in a 2.4-fold increase in activity (Fig. 4, inset, cross-hatched bar). In the presence of the VGCC blocker nimodipine, the ability of [Ca2+]o addition alone to stimulate the cyclase was completely abolished (Fig. 4A, inset, left-hatched bar), whereas cells pretreated with TG still showed a robust regulation of ACVIII (approximately 1.9-fold stimulation; Fig. 4A, inset, horizontal striped bar). Thus, basal VGCC activity in resting cells did contribute significantly to the stimulation of ACVIII. Conversely, there was no indication of CCE in resting, untreated cells, because the Ca2+ entry generated by Ca2+ addition was completely blocked by nimodipine.



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Examination of the presence of CCE in GH4C1 cells. [Ca2+]i and cAMP accumulation was determined in GH4C1 cells as described under "Experimental Procedures." A, [Ca2+]i measurements in populations of Fura-2-loaded GH4C1 cells maintained in nominally Ca2+-free Krebs buffer containing IBMX (100 µM). Cells were either untreated (b and d) or treated with TG (100 nM, 60 s; a and c) before the addition of [Ca2+]o (2 mM, 300 s) in the absence or presence of nimodipine (1 µM, 300 s; c and d). Trace averages were generated by averaging 5-s, overlapping data segments and are overlaid on the actual traces. Inset, cAMP accumulation was measured in ACVIII-expressing GH4C1 cells maintained in nominally Ca2+-free Krebs buffer. Control cells (forskolin stimulation alone, open bars) were compared with untreated (right-hatched and left-hatched bars) and TG-treated cells (100 nM; cross-hatched and horizontal striped bars), in the absence or presence of nimodipine (1 µM, right-hatched and horizontal striped bars). B, populations of Fura-2-loaded GH4C1 cells were incubated in nominally Ca2+-free Krebs buffer containing IBMX (100 µM) before the addition of TG (100 nM, 60 s; a and c) and/or KCl (10 mM, 300 s; a and b), along with [Ca2+]o (0.5 mM, 300 s). Inset, cAMP accumulation was measured in ACVIII-expressing GH4C1 cells maintained in nominally Ca2+-free Krebs buffer. Control cells (forskolin stimulation alone, open bar) were compared with TG-treated (100 nM; right-hatched bar), KCl-treated (10 mM; cross-hatched bar), and TG/KCl-treated (left-hatched bar) cells in the presence of [Ca2+]o (0.5 mM). Asterisks denote significant differences from the TG/KCl condition (left-hatched bar) as judged by Student's t test (p < 0.005). C, cAMP accumulation was measured in ACVIII-expressing GH4C1 cells maintained in nominally Ca2+-free Krebs buffer. Control cells (forskolin stimulation alone, open bar) were compared with untreated (left-hatched bar), TG-treated (100 nM; cross-hatched bar), KCl-treated (10 mM, horizontal striped bar), and TG/KCl-treated (vertical striped bar) cells in the presence of [Ca2+]o (0.5 mM). Cells were assayed in the presence of nimodipine (1 µM), which was added at the beginning of the 1-min cAMP accumulation assay. The same fold-stimulation is observed in ACVIII-expressing cells after activation of CCE or VGCC-mediated Ca2+ entry under basal conditions, i.e. in the absence of forskolin. Data are representative of several similar experiments.

Another method to verify the presence of CCE is to determine whether the combination of the two Ca2+ entry mechanisms (CCE and VGCC) yields augmented [Ca2+]i rises and/or regulation of ACVIII. Populations of GH4C1 cells were treated with TG (Fig. 4B, traces a and c), followed by depolarization with KCl (10 mM; traces a and b) and addition of [Ca2+]o (0.5 mM; note that lower [Ca2+]o values were used to prevent maximal Ca2+ entry with depolarization alone). TG treatment alone (trace c) resulted in a modest [Ca2+]i rise of approximately 250 nM after the addition of [Ca2+]o. Activation of VGCCs with the addition of [K+]o along with [Ca2+]o resulted in a [Ca2+]i rise of approximately 400 nM (trace b). Combining the two (TG and [K+]o (trace a)) resulted in an augmented [Ca2+]i rise of approximately 510 nM. The combination of CCE and VGCC-mediated Ca2+ entry also resulted in increased regulation of ACVIII (Fig. 4B, inset). GH4C1 cells that were pretreated with TG before [Ca2+]o addition showed a stimulation of ACVIII by approximately 2.4-fold as compared with control, untreated cells (Fig. 4B, inset, open bar versus right-hatched bar). Depolarization of the cells by the addition of [K+]o along with [Ca2+]o also resulted in a stimulation of the cyclase, giving an approximately 2.2-fold increase (Fig. 4B, inset, cross-hatched bar). Combination of the two modes of Ca2+ entry resulted in an augmented regulation of ACVIII, yielding an approximately 2.8-fold stimulation (Fig. 4B, inset, left-hatched bar). In the same experiment as Fig. 4B, the ability of VGCC-mediated Ca2+ entry activated by KCl addition to regulate the cyclase was also blocked by nimodipine (Fig. 4C). Furthermore, treatment of the cells with both TG and KCl in the presence of nimodipine resulted in a stimulation of ACVIII that was identical to that seen with TG treatment alone (Fig. 4C, cross-hatched versus vertical-striped bars). Therefore, the two Ca2+ entry mechanisms, CCE and VGCC-mediated Ca2+ entry, in combination, led to an augmentation in both the [Ca2+]i rise and the magnitude of the stimulation of ACVIII produced by either Ca2+ entry mechanism alone, indicating they are separate Ca2+ entry processes.

The previous results revealed the presence of CCE with the use of nimodipine to block the spontaneously active VGCCs. It was also shown that the two Ca2+ entry mechanisms are quite similar in their ability to regulate ACVIII when the underlying VGCC-mediated Ca2+ entry is removed from the CCE (cf. Fig. 4, A versus B, cross-hatched bars). Although the effects of VGCC-mediated Ca2+ entry and "pure" CCE on the regulation of the cyclase are similar, the corresponding [Ca2+]i rises are quite different (Fig. 5, A and B). A robust [Ca2+]i rise was generated by VGCC-mediated Ca2+ entry triggered by [K+]o (Fig. 5A, 10 mM; trace a), reaching a peak of approximately 700 nM, whereas TG-mediated Ca2+ entry reached a peak of approximately 250 nM (Fig. 5B, trace a). In the presence of nimodipine (1 µM), the [Ca2+]i rise generated by depolarization was almost eliminated (Fig. 5A, trace b), dropping to approximately 120 nM, whereas TG-mediated Ca2+ entry was decreased to approximately 170 nM (Fig. 5B, trace b). This relatively small [Ca2+]i rise generated by TG treatment in the presence of nimodipine, "pure" CCE, could still effectively stimulate ACVIII (cf. Fig. 4C). Therefore, a [Ca2+]i rise of approximately 170 nM generated by CCE was as efficacious as the approximately 700 nM [Ca2+]i rise produced by VGCC-mediated Ca2+ entry in regulating ACVIII.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of nimodipine on TG- and VGCC-mediated Ca2+ entry. [Ca2+]i was determined in GH4C1 cells as described under "Experimental Procedures." A and B, [Ca2+]i measurements were made in GH4C1 cells maintained in nominally Ca2+-free Krebs buffer. A, cells were treated with KCl/[Ca2+]o (10 mM/2 mM) at 300 s in the absence (a) or presence (b) of nimodipine (1 µM, 300 s). B, cells were treated with TG (100 nM, 60 s), followed by the addition of [Ca2+]o (2 mM, 300 s) in the absence (a) or presence (b) of nimodipine (1 µM, 300 s). Data are representative of several similar experiments.

The observation that a modest amount of Ca2+ entry via CCE was able to stimulate ACVIII to a similar extent as a much more robust VGCC-mediated Ca2+ entry prompted us to investigate whether Ca2+ release from intracellular stores could also regulate the exogenously expressed ACVIII. Although TG releases intracellular Ca2+, the small release occurs over a prolonged period. Phospholipase C-coupled agonists produce a much more rapid and significant [Ca2+]i rise. Addition of TRH (100 nM) to populations of GH4C1 cells maintained in Ca2+-free Krebs buffer resulted in a very rapid, large [Ca2+]i rise of approximately 500 nM (Fig. 6A). Intracellular Ca2+ can also be released by Ca2+ ionophores. Treatment of GH4C1 cells incubated in Ca2+-free Krebs buffer with ionomycin (IM; 2 µM) yielded a rapid and robust [Ca2+]i rise that reached approximately 900 nM (Fig. 6B). The ability of these large [Ca2+]i rises generated by releasing intracellular Ca2+ with either TRH or IM to stimulate ACVIII was explored. cAMP accumulation was measured in GH4C1 cells that were either uninfected (open bars) or infected with the ACVIII-containing virus (hatched bars) and maintained in Ca2+-free Krebs buffer before the addition of forskolin along with TRH (100 nM; Fig. 6A, inset) or IM (2 µM; Fig. 6B, inset). Neither TRH or IM stimulated ACVIII activity as compared with the uninfected control cells. Therefore, the triggering of a large [Ca2+]i rise due to the release of Ca2+ from intracellular stores via either inositol 1,4,5-trisphosphase generation or ionophore-mediated release did not affect ACVIII.



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of Ca2+ release from intracellular stores on ACVIII expressed in GH4C1 cells. [Ca2+]i and cAMP accumulation was determined in GH4C1 cells as described under "Experimental Procedures." A and B, [Ca2+]i measurements were made in GH4C1 cells maintained in Ca2+-free Krebs buffer. Ca2+ was released from intracellular stores using either TRH (100 nM, 60 s; A) or IM (2 µM, 60 s; B) with the resultant [Ca2+]i rises shown. Insets, cAMP accumulation was measured in either uninfected (open bars) or ACVIII-infected cells (hatched bars), as indicated. Cells in Ca2+-free Krebs buffer were treated with either forskolin/TRH (10 µM/100 nM; A) or forskolin/IM (10 µM/2 µM; B).



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

One of the more surprising findings to emerge from the study of Ca2+-sensitive adenylyl cyclases---whether they are expressed heterologously or endogenously---is their strict dependence on CCE for their regulation in nonexcitable cells (2, 3). Release from internal stores (4) or Ca2+ entry via ionophore (2, 3) or triggered by arachidonic acid (7) is without effect. Extremely little is known about the regulation of Ca2+-sensitive adenylyl cyclases in excitable cells. In the present study, we have investigated the regulation of ACVIII by Ca2+ in an excitable cell line, rat anterior pituitary tumor-derived GH4C1 cells. The study addressed four major issues: (a) whether Ca2+ entry via VGCCs could regulate a Ca2+-stimulable adenylyl cyclase, (b) whether the modest CCE expressed in these cells could regulate the adenylyl cyclase, (c) whether Ca2+ release from internal stores could regulate adenylyl cyclase in this excitable cell line, and (d) whether the relative magnitudes of the [Ca2+]i rises generated by CCE and VGCCs could predict the degree of stimulation of the adenylyl cyclase.

Does Ca2+ entry via VGCCs regulate a Ca2+-stimulable adenylyl cyclase? Ca2+-sensitive adenylyl cyclases are expressed mainly in excitable tissues, with the Ca2+-stimulable ACI and ACVIII found exclusively in neuronal cells (32-34), whereas ACV and ACVI, the Ca2+-inhibitable isoforms, predominate in cardiac tissue (35-37). Given the expression pattern of Ca2+-sensitive adenylyl cyclases and the prevalence of VGCCs in those tissues, we were surprised at the paucity in the literature on the ability of VGCC-mediated Ca2+ entry to regulate cAMP accumulation. Although there is abundant literature on the ability of the cAMP-signaling cascade to regulate L-type VGCCs (reviewed in Ref. 38), little has been done to directly address the effect and the potential feedback of Ca2+ entry by such channels on adenylyl cyclase activity. An exception was a study showing that Ca2+ entry through VGCCs inhibited adenylyl cyclase activity in embryonic chick ventricle myocytes (39). In the case of Ca2+/calmodulin stimulation of adenylyl cyclase activity, depolarization of hippocampal CA1 slices by 50 mM KCl increased cAMP accumulation, which was blocked by calmodulin antagonists (9). Furthermore, in cultured cerebellar granular cells, depolarization-induced Ca2+ entry stimulated cAMP accumulation, which was blocked by nimodipine (8). The current study has extended these findings in showing that heterologous expression of a specific Ca2+-stimulable adenylyl cyclase, ACVIII, is regulated by Ca2+ entry through VGCCs in a clonal cell line. The potent block of this effect by nimodipine establishes that the effect is mediated by L-type VGCCs (40).

Does CCE regulate a Ca2+-stimulable adenylyl cyclase in an excitable cell? The potential role of CCE in excitable cells has been overshadowed by the more robust Ca2+ entry generated by VGCCs. Also hindering the study of CCE not only in excitable cells, but in all cell types, is the uncertainty of the molecular nature of the channels responsible for CCE. The Drosophila transient receptor potential protein, which is involved in insect phototransduction, is increasingly being viewed as a putative CCE channel (41). A family of mammalian transient receptor potential protein homologues have now been described, each possessing different activation and conductance characteristics when heterologously expressed (reviewed in Refs. 42 and 43). Additionally, several of the mammalian transient receptor potential protein isoforms have been found in various brain regions, further suggesting a potential role for CCE in excitable cells (44, 45). One such role for CCE in excitable cells emerged from the work of Koizumi and Inoue (46), who showed in PC12 cells that caffeine, TG, and cyclopiazoic acid, all agents that release intracellular Ca2+ and therefore stimulate CCE, evoked dopamine release. Exocytosis has also been shown to be regulated by CCE in adrenal chromaffin cells (47). Our findings show that CCE, which gives rise to a modest increase in [Ca2+]i, was very effective at stimulating ACVIII. Furthermore, the findings that CCE augmented the stimulation of ACVIII by VGCC-mediated Ca2+ entry in a manner that was insensitive to nimodipine establishes the fact that CCE can regulate the cyclase.

Does Ca2+ release from intracellular Ca2+ stores regulate ACVIII in an excitable cell? We have previously shown an inability of Ca2+ release to regulate Ca2+-sensitive adenylyl cyclases in nonexcitable cells (4), and furthermore, we have shown that Ca2+ regulation of adenylyl cyclases relies totally on Ca2+ entry through CCE channels (3). In the current study, releasing intracellular Ca2+ with either phospholipase C-coupled agonists or ionophore was without effect on ACVIII activity. Similar to our findings, dopamine release in PC12 cells was insensitive to Ca2+ release from intracellular stores and in fact depended on Ca2+ entry (46, 48). Thus we are now inclined to generalize that Ca2+ release from intracellular stores will not regulate Ca2+-sensitive adenylyl cyclases, regardless of cell type.

Does the magnitude of the [Ca2+]i rise generated by various means predict the amount of stimulation of ACVIII? We have compared the ability of three modes of raising [Ca2+]i, VGCC-mediated Ca2+ entry, CCE, and Ca2+ release from internal stores, to stimulate ACVIII. The [Ca2+]i values achieved by VGCC-mediated Ca2+ entry and ionophore-mediated Ca2+ release were both substantial (peak values of approximately 700 and 900 nM, respectively), with CCE being much more modest (approximately 250 nmM). However, the magnitude of these [Ca2+]i rises in no way predicts the amount of stimulation of ACVIII. The large [Ca2+]i rise promoted by Ca2+ release was totally without effect, whereas a similar peak [Ca2+]i rise generated by VGCC-mediated Ca2+ entry was very potent at stimulating ACVIII. CCE, the least effective in terms of producing a large [Ca2+]i rise, was as efficacious as VGCC-mediated Ca2+ entry in stimulating ACVIII.

Obviously the inability of the magnitude of different forms of [Ca2+]i rise to predict subsequent effects on ACVIII is due to the unresolved spatial information provided by Fura-2 in population measurements of [Ca2+]i. One approach to addressing this issue directly would be to measure the [Ca2+] in the vicinity of the cyclase by an adenylyl cyclase/aequorin chimera (49), with the prediction that the chimera would report similar [Ca2+] in response to VGCC and CCE and far less in response to release from stores. It is becoming increasingly obvious that the plasma membrane is not uniform in lipid composition or in the distribution of regulatory elements. Recent findings indicate that adenylyl cyclases must occur in cholesterol-rich domains to be susceptible to CCE in nonexcitable cells (50). In this context, it is also relevant that transient receptor potential protein 1 has recently been reported in rafts (51). It would be very interesting to determine whether the same residence in cholesterol-rich domains would apply to the adenylyl cyclase or to any of these channels in excitable cells. The nonequivalence in the ability of VGCC-mediated Ca2+ entry and CCE to regulate ACVIII in GH4C1 cells may indicate that the adenylyl cyclase is closer to the CCE channel than the VGCC. It would be expected, and indeed it has been predicted, that [Ca2+] of 1 µM would be found up to approximately 50 nm from a VGCC (52), whereas an equal [Ca2+] would be found approximately 5-10 nm from the mouth of a CCE channel (53), given the conductances of L-type and Icrac channels reported in the literature. Furthermore, the moderately high affinity for Ca2+ of Fura-2 makes it likely that the [Ca2+]i achieved by VGCC in the cytosol is underestimated (28). Consequently, the VGCC may be even more distant and in quite a different domain from the adenylyl cyclase.

It seems fair to conclude from these studies that the intimate relationship that was first demonstrated between CCE channels and adenylyl cyclase in nonexcitable cells is maintained in excitable cells, even though the adenylyl cyclase is also susceptible to the very robust VGCC-mediated Ca2+ entry present in these cells. Whether this association is maintained by colocalization within cholesterol-rich domains of the plasma membrane, as in nonexcitable cells (50), or by some additional process remains to be determined.


    ACKNOWLEDGEMENTS

We thank Drs. J. Karpen, T. Rich, and A. Zweifach for their useful comments on the manuscript.


    FOOTNOTES

* This work was supported by National Institutes of Health Grant NS 28389 (to D. M. F. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Pharmacology, Box C-236, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262. Tel.: 303-315-8964; Fax: 303-315-7097; E-mail: dermot.cooper@uchsc.edu.

Published, JBC Papers in Press, September 28, 2000, DOI 10.1074/jbc.M006606200


    ABBREVIATIONS

The abbreviations used are: [Ca2+]i, cytosolic [Ca2+]; CCE, capacitative Ca2+ entry; ACVIII, adenylyl cyclase type VIII; VGCC, voltage-gated calcium channel; TG, thapsigargin; [Ca2+]o, extracellular [Ca2+]; [K+]o, extracellular [K+]; TRH, thyrotropin-releasing hormone; TP, terminal protein; CMV, cytomegalovirus; m.o.i., multiplicity of infection; IBMX, 3-isobutyl-1-methylxanthine; IM, ionomycin.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Cooper, D. M. F., Mons, N., and Karpen, J. W. (1995) Nature 374, 421-424
2. Fagan, K. A., Mahey, R., and Cooper, D. M. F. (1996) J. Biol. Chem. 271, 12438-12444
3. Fagan, K. A., Mons, N., and Cooper, D. M. F. (1998) J. Biol. Chem. 273, 9297-9305
4. Chiono, M., Mahey, R., Tate, G., and Cooper, D. M. F. (1995) J. Biol. Chem. 270, 1149-1155
5. Burnay, M. M., Vallotton, M. B., Capponi, A. M., and Rossier, M. F. (1998) Biochem. J. 330, 21-27
6. Watson, E. L., Wu, Z., Jacobson, K. L., Storm, D. R., Singh, J. C., and Ott, S. M. (1998) Am. J. Physiol. 274, C557-C565
7. Shuttleworth, T. J., and Thompson, J. L. (1999) J. Biol. Chem. 274, 31174-31178
8. Cooper, D. M. F., Schell, M. J., Thorn, P., and Irvine, R. F. (1998) J. Biol. Chem. 273, 27703-27707
9. Chetkovich, D. M., and Sweatt, J. D. (1993) J. Neurochem. 61, 1933-1942
10. Schlegel, W., Winiger, B. P., Mollard, P., Vacher, P., Wuarin, F., Zahnd, G. R., Wollheim, C. B., and Dufy, B. (1987) Nature 329, 719-721
11. Mollard, P., Dufy, B., Vacher, P., Barker, J. L., and Schlegel, W. (1990) Biochem. J. 268, 345-352
12. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. (1977) J. Gen. Virol. 36, 59-72
13. Schaack, J., Langer, S., and Guo, X. L. (1995) J. Virol. 69, 3920-3923
14. Jones, N., and Shenk, T. (1978) Cell 13, 181-188
15. Chinnadurai, G., Chinnadurai, S., and Green, M. (1978) J. Virol. 26, 195-199
16. Gomez-foix, A. M., Coats, W. S., Baque, S., Alam, T., Gerard, R. D., and Newgard, C. B. (1992) J. Biol. Chem. 267, 25129-25134
17. Jordan, M., Schallhorn, A., and Wurm, F. M. (1996) Nucleic Acids Res. 24, 596-601
18. Pastan, I., and Perlman, R. L. (1971) Nat. New Biol. 229, 5-7
19. Engel, D. A., Muller, U., Gedrich, R. W., Eubanks, J. S., and Shenk, T. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 3957-3961
20. Gedrich, R. W., and Engel, D. A. (1995) J. Virol. 69, 2333-2340
21. Lee, B. H., and Mathews, M. B. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4481-4486
22. Whalen, S. G., Marcellus, R. C., Whalen, A., Ahn, N. G., Ricciardi, R. P., and Branton, P. E. (1997) J. Virol. 71, 3545-3553
23. Smith, D. H., Kegler, D. M., and Ziff, E. B. (1985) Mol. Cell. Biol. 5, 2684-2696
24. Chinnadurai, G., Chinnadurai, S., and Brusca, J. (1979) J. Virol. 32, 623-628
25. Evans, T., Smith, M. M., Tanner, L. I., and Harden, T. K. (1984) Mol. Pharmacol. 26, 395-404
26. Fagan, K. A., Rich, T. C., Tolman, S., Schaack, J., Karpen, J. W., and Cooper, D. M. F. (1999) J. Biol. Chem. 274, 12445-12453
27. Salomon, Y., Londos, C., and Rodbell, M. (1974) Anal. Biochem. 58, 541-548
28. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450
29. Paulssen, R. H., Johansen, P. W., Gordeladze, J. O., Nymoen, O., Paulssen, E. J., and Gautvik, K. M. (1994) Eur. J. Biochem. 222, 97-103
30. Mollard, P., Theler, J. M., Guerineau, N., Vacher, P., Chiavaroli, C., and Schlegel, W. (1994) J. Biol. Chem. 269, 25158-25164
31. Putney, J. W., Jr. (1986) Cell Calcium 7, 1-12
32. Xia, Z. G., Refsdal, C. D., Merchant, K. M., Dorsa, D. M., and Storm, D. R. (1991) Neuron 6, 431-443
33. Cali, J. J., Zwaagstra, J. C., Mons, N., Cooper, D. M. F., and Krupinski, J. (1994) J. Biol. Chem. 269, 12190-12195
34. Mons, N., and Cooper, D. M. F. (1995) Trends Neurosci. 18, 536-542
35. Ishikawa, Y., Katsushika, S., Chen, L., Halnon, N. J., Kawabe, J., and Homcy, C. J. (1992) J. Biol. Chem. 267, 13553-13557
36. Yoshimura, M., and Cooper, D. M. F. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6716-6720
37. Krupinski, J., Lehman, T. C., Frankenfield, C. D., Zwaagstra, J. C., and Watson, P. A. (1992) J. Biol. Chem. 267, 24858-24862
38. Rossie, S. (1999) Adv. Second Messenger Phosphoprotein Res. 33, 23-48
39. Yu, H. J., Ma, H., and Green, R. D. (1993) Mol. Pharmacol. 44, 689-693
40. Furukawa, T., Yamakawa, T., Midera, T., Sagawa, T., Mori, Y., and Nukada, T. (1999) J. Pharmacol. Exp. Ther. 291, 464-473
41. Putney, J. W., and McKay, R. R. (1999) Bioessays 21, 38-46
42. Zhu, X., Jiang, M., Peyton, M., Boulay, G., Hurst, R., Stefani, E., and Birnbaumer, L. (1996) Cell 85, 661-671
43. Harteneck, C., Plant, T. D., and Schultz, G. (2000) Trends Neurosci. 23, 159-166
44. Otsuka, Y., Sakagami, H., Owada, Y., and Kondo, H. (1998) Tohoku J. Exp. Med. 185, 139-146
45. Philipp, S., Hambrecht, J., Braslavski, L., Schroth, G., Freichel, M., Murakami, M., Cavalie, A., and Flockerzi, V. (1998) EMBO J. 17, 4274-4282
46. Koizumi, S., and Inoue, K. (1998) Biochem. Biophys. Res. Commun. 244, 293-297
47. Fomina, A. F., and Nowycky, M. C. (1999) J. Neurosci. 19, 3711-3722
48. Taylor, S. C., and Peers, C. (1999) J. Neurochem. 73, 874-880
49. Nakahashi, Y., Nelson, E., Fagan, K. A., Gonzales, E., Guillou, J. L., and Cooper, D. M. F. (1997) J. Biol. Chem. 272, 18093-18097
50. Fagan, K. A., Smith, K. E., and Cooper, D. M. F. (2000) J. Biol. Chem. 275, 26530-26537
51. Lockwich, T. P., Liu, X. B., Singh, B. B., Jadlowiec, J., Weiland, S., and Ambudkar, I. S. (2000) J. Biol. Chem. 275, 11934-11942
52. Naraghi, M., and Neher, E. (1997) J. Neurosci. 17, 6961-6973
53. Zweifach, A., and Lewis, R. S. (1995) J. Gen. Physiol. 105, 209-226


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Tsujikawa, Y. Song, M. Watanabe, H. Masumiya, S. A. Gupte, R. Ochi, and T. Okada
Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its -adrenergic enhancement in ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H285 - H292.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Willoughby and D. M. F. Cooper
Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains
Physiol Rev, July 1, 2007; 87(3): 965 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. C. Buser, E. K. Gass-Handel, S. L. Wyszomierski, W. Doppler, S. A. Leonhardt, J. Schaack, J. M. Rosen, H. Watkin, S. M. Anderson, and D. P. Edwards
Progesterone Receptor Repression of Prolactin/Signal Transducer and Activator of Transcription 5-Mediated Transcription of the {beta}-Casein Gene in Mammary Epithelial Cells
Mol. Endocrinol., January 1, 2007; 21(1): 106 - 125.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Singaravelu, C. Lohr, and J. W. Deitmer
Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes.
J. Neurosci., September 13, 2006; 26(37): 9579 - 9592.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. E. Gonzalez-Iglesias, Y. Jiang, M. Tomic, K. Kretschmannova, S. A. Andric, H. Zemkova, and S. S. Stojilkovic
Dependence of Electrical Activity and Calcium Influx-Controlled Prolactin Release on Adenylyl Cyclase Signaling Pathway in Pituitary Lactotrophs
Mol. Endocrinol., September 1, 2006; 20(9): 2231 - 2246.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Willoughby and D. M. F. Cooper
Ca2+ stimulation of adenylyl cyclase generates dynamic oscillations in cyclic AMP
J. Cell Sci., March 1, 2006; 119(5): 828 - 836.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Crossthwaite, A. Ciruela, T. F. Rayner, and D. M. F. Cooper
A Direct Interaction between the N Terminus of Adenylyl Cyclase AC8 and the Catalytic Subunit of Protein Phosphatase 2A
Mol. Pharmacol., February 1, 2006; 69(2): 608 - 617.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Willoughby, N. Masada, A. J. Crossthwaite, A. Ciruela, and D. M. F. Cooper
Localized Na+/H+ Exchanger 1 Expression Protects Ca2+-regulated Adenylyl Cyclases from Changes in Intracellular pH
J. Biol. Chem., September 2, 2005; 280(35): 30864 - 30872.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Brini, M. Miuzzo, N. Pierobon, A. Negro, and M. C. Sorgato
The Prion Protein and Its Paralogue Doppel Affect Calcium Signaling in Chinese Hamster Ovary Cells
Mol. Biol. Cell, June 1, 2005; 16(6): 2799 - 2808.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Dyer, Y. Liu, I. P. de la Huerga, and C. W. Taylor
Long Lasting Inhibition of Adenylyl Cyclase Selectively Mediated by Inositol 1,4,5-Trisphosphate-evoked Calcium Release
J. Biol. Chem., March 11, 2005; 280(10): 8936 - 8944.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Crossthwaite, T. Seebacher, N. Masada, A. Ciruela, K. Dufraux, J. E. Schultz, and D. M. F. Cooper
The Cytosolic Domains of Ca2+-sensitive Adenylyl Cyclases Dictate Their Targeting to Plasma Membrane Lipid Rafts
J. Biol. Chem., February 25, 2005; 280(8): 6380 - 6391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. S. Murthy, H. Zhou, J. Huang, and S. N. Pentyala
Activation of PLC-{delta}1 by Gi/o-coupled receptor agonists
Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1679 - C1687.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. A. Antoni, A. A. Sosunov, A. Haunso, J. M. Paterson, and J. Simpson
Short-Term Plasticity of Cyclic Adenosine 3',5'-Monophosphate Signaling in Anterior Pituitary Corticotrope Cells: The Role of Adenylyl Cyclase Isotypes
Mol. Endocrinol., April 1, 2003; 17(4): 692 - 703.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. L. Cioffi, T. M. Moore, J. Schaack, J. R. Creighton, D. M.F. Cooper, and T. Stevens
Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase
J. Cell Biol., June 24, 2002; 157(7): 1267 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
R. K. Sunahara and R. Taussig
Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling
Mol. Interv., June 1, 2002; 2(3): 168 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. D. Bootman, P. Lipp, and M. J. Berridge
The organisation and functions of local Ca2+ signals
J. Cell Sci., March 8, 2002; 114(12): 2213 - 2222.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/51/40187    most recent
M006606200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fagan, K. A.
Right arrow Articles by Cooper, D. M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fagan, K. A.
Right arrow Articles by Cooper, D. M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement